Inflarx Nv Stock Buy Hold or Sell Recommendation
| IFRX Stock | USD 2.36 0.05 2.16% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding InflaRx NV is 'Strong Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell InflaRx NV given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for InflaRx NV, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out InflaRx NV Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy InflaRx Stock please use our How to Invest in InflaRx NV guide. In addition, we conduct extensive research on individual companies such as InflaRx and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards InflaRx NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
InflaRx |
Execute InflaRx NV Buy or Sell Advice
The InflaRx recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on InflaRx NV. Macroaxis does not own or have any residual interests in InflaRx NV or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute InflaRx NV's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | Good | Details | |
Volatility | Unstable | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
InflaRx NV Trading Alerts and Improvement Suggestions
| InflaRx NV appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 63.09 K. Net Loss for the year was (42.67 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| InflaRx NV currently holds about 23.68 M in cash with (37.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.54. | |
| InflaRx NV has a poor financial position based on the latest SEC disclosures |
InflaRx NV Returns Distribution Density
The distribution of InflaRx NV's historical returns is an attempt to chart the uncertainty of InflaRx NV's future price movements. The chart of the probability distribution of InflaRx NV daily returns describes the distribution of returns around its average expected value. We use InflaRx NV price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of InflaRx NV returns is essential to provide solid investment advice for InflaRx NV.
| Mean Return | 0.86 | Value At Risk | -4.52 | Potential Upside | 9.09 | Standard Deviation | 4.60 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of InflaRx NV historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
InflaRx NV Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to InflaRx NV or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that InflaRx NV's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a InflaRx stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.82 | |
β | Beta against Dow Jones | 0.41 | |
σ | Overall volatility | 4.60 | |
Ir | Information ratio | 0.17 |
InflaRx NV Volatility Alert
InflaRx NV shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure InflaRx NV's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact InflaRx NV's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.InflaRx NV Fundamentals Vs Peers
Comparing InflaRx NV's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze InflaRx NV's direct or indirect competition across all of the common fundamentals between InflaRx NV and the related equities. This way, we can detect undervalued stocks with similar characteristics as InflaRx NV or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of InflaRx NV's fundamental indicators could also be used in its relative valuation, which is a method of valuing InflaRx NV by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare InflaRx NV to competition |
| Fundamentals | InflaRx NV | Peer Average |
| Return On Equity | -0.45 | -0.31 |
| Return On Asset | -0.22 | -0.14 |
| Current Valuation | 87.78 M | 16.62 B |
| Shares Outstanding | 58.88 M | 571.82 M |
| Shares Owned By Insiders | 7.34 % | 10.09 % |
| Shares Owned By Institutions | 22.52 % | 39.21 % |
| Number Of Shares Shorted | 157.04 K | 4.71 M |
| Price To Earning | (7.90) X | 28.72 X |
| Price To Book | 1.98 X | 9.51 X |
| Price To Sales | 1,431 X | 11.42 X |
| Revenue | 63.09 K | 9.43 B |
| EBITDA | (44.81 M) | 3.9 B |
| Net Income | (42.67 M) | 570.98 M |
| Cash And Equivalents | 23.68 M | 2.7 B |
| Cash Per Share | 0.54 X | 5.01 X |
| Total Debt | 1.12 M | 5.32 B |
| Debt To Equity | 0.01 % | 48.70 % |
| Current Ratio | 9.93 X | 2.16 X |
| Book Value Per Share | 1.74 X | 1.93 K |
| Cash Flow From Operations | (37.81 M) | 971.22 M |
| Short Ratio | 5.17 X | 4.00 X |
| Earnings Per Share | (1.03) X | 3.12 X |
| Target Price | 8.13 | |
| Number Of Employees | 62 | 18.84 K |
| Beta | 1.58 | -0.15 |
| Market Capitalization | 151 M | 19.03 B |
| Total Asset | 120.21 M | 29.47 B |
| Retained Earnings | (286.13 M) | 9.33 B |
| Working Capital | 92.62 M | 1.48 B |
| Current Asset | 67.08 M | 9.34 B |
| Current Liabilities | 2.74 M | 7.9 B |
| Net Asset | 120.21 M |
InflaRx NV Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as InflaRx . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About InflaRx NV Buy or Sell Advice
When is the right time to buy or sell InflaRx NV? Buying financial instruments such as InflaRx Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having InflaRx NV in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run SRI Sustainable Growth Thematic Idea Now
SRI Sustainable Growth
Socially responsible investments that include companies making a positive, sustainable or social impact and exclude those making a negative impact. The SRI Sustainable Growth theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize SRI Sustainable Growth Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for InflaRx Stock Analysis
When running InflaRx NV's price analysis, check to measure InflaRx NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InflaRx NV is operating at the current time. Most of InflaRx NV's value examination focuses on studying past and present price action to predict the probability of InflaRx NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InflaRx NV's price. Additionally, you may evaluate how the addition of InflaRx NV to your portfolios can decrease your overall portfolio volatility.